Department of Medicine C and the Rheumatic Disease Unit, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
Autoimmun Rev. 2010 Mar;9(5):A325-9. doi: 10.1016/j.autrev.2009.11.012. Epub 2009 Dec 21.
Spondyloarthropathies (SPA) are a group of common inflammatory rheumatic disorders characterized by axial and or peripheral arthritis, associated with enthesitis, dactylitis and potential extra-articular manifestations such as uveitis and skin rash. The diseases which comprise the group, share a common genetic predisposition, the HLA-B27 gene, however this association varies markedly among the various SPAs and among different ethnic groups. Environmental factors seem to be triggering the diseases in the genetically predisposed. The radiographic hallmark of the group is sacroiliitis, which when present is of help in the diagnosis. Various sets of diagnostic and classification criteria were developed over the years with the latest European Spondyloarthropathy Study Group (ESSG) criteria which are the most widely used. MRI changes have been included in the new classification criteria of early axial SPA and are now considered as a major tool in the diagnosis. Until recent years, there were no real disease modifying anti-rheumatic drugs which were able to halt the disease progression. Tumor necrosis factor (TNF)-alfa blocking agents, have now become the mainstream of therapy providing the patients an effective treatment option.
脊柱关节炎(SPA)是一组常见的炎性风湿性疾病,其特征为中轴和/或外周关节炎,伴有附着点炎、指(趾)炎和潜在的关节外表现,如葡萄膜炎和皮疹。该组疾病具有共同的遗传易感性,即 HLA-B27 基因,但这种关联在各种 SPA 和不同种族之间差异很大。环境因素似乎在遗传易感者中引发了这些疾病。该组疾病的放射学特征是骶髂关节炎,当出现时有助于诊断。多年来,已经制定了各种诊断和分类标准,其中最新的欧洲脊柱关节炎研究组(ESSG)标准是应用最广泛的。MRI 改变已被纳入早期中轴 SPA 的新分类标准,现在被认为是诊断的主要工具。直到最近几年,还没有真正的能阻止疾病进展的疾病修饰抗风湿药物。肿瘤坏死因子(TNF)-α 阻断剂现已成为治疗的主流,为患者提供了有效的治疗选择。